Alexion Pharmaceuticals: Nice Earnings, Too Expensive?

On a day when biotech stocks like Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN) and Celgene (CELG) are flying, few are flying higher than Alexion Pharmaceuticals (ALXN). Alexion has gained 7.1% after the biotech company reported a profit of $127 a share, topping analyst forecasts for $1.15. Alexion also raised its full-year guidance to between $5.15 and $5.20 [...]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.